KPV Capsule — lifestyle
    Gut SupportInflammation Signaling
    CAPSULEComing soon

    500 mcg per capsule · 1-month supply

    KPV Capsule

    A three-amino-acid peptide studied for inflammatory signaling in the gut lining, taken as a daily capsule.

    • Studied for inflammatory signaling in the gut lining and skin
    • Oral acid-resistant capsule, taken daily. No needle
    • Single-ingredient, compounded by a licensed U.S. pharmacy

    The KPV protocol will soon be available for purchase.

    Join the waitlist and we'll email you when ordering opens.

    Unsubscribe at any time.

    Verify Approval for www.edgerx.orgA4M — Medicine RedefinedCOMPOUNDEDIN THE U.S.A.

    US board-certified physician review

    A board-certified physician builds your protocol.

    US-licensed 503A pharmacy

    Pharmaceutical-grade purity, prescribed by your physician.

    Shipped discreetly to your door

    Subscription billed monthly. Cancel anytime.

    How KPV works

    KPV is the three-amino-acid tail of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide, studied on its own for its effects on inflammatory signaling.

    KPV is a tripeptide, Lys-Pro-Val, that corresponds to the final three amino acids of α-MSH, a hormone involved in pigmentation, appetite, and immune signaling. The fragment has been studied on its own for the immune-modulating part of that activity, without the hormone's other effects.

    In preclinical research, KPV has been examined for its ability to reduce inflammatory signaling in cells of the gut lining and skin, including in animal models of intestinal inflammation. Some of that work has looked specifically at oral delivery, which is why KPV is compounded as a capsule rather than an injection.

    Why KPV

    Gut comfort is often the first thing to slip in a heavy training or travel week. KPV is a peptide that research has examined in exactly that tissue, and one of the few covered peptides with an oral route.

    EdgeRx offers KPV as a single-ingredient protocol: an acid-resistant capsule prescribed by a U.S. board-certified physician for you specifically, compounded by a licensed U.S. 503A pharmacy, and shipped refrigerated.

    What to expect

    A daily oral capsule, typically run over several weeks. Your physician sets expectations with you based on your goals and history rather than a fixed timeline.

    • A capsule you swallow with water. No needle.
    • An acid-resistant capsule designed to pass through the stomach intact
    • A patient-specific prescription with physician oversight throughout
    • Refrigerated, cold-chain shipping from the compounding pharmacy

    How you take it

    The routine

    One acid-resistant capsule, swallowed with water, typically once daily.

    Starting dose

    Set by your prescribing physician after your medical assessment.

    Storage

    Refrigerated. Ships cold-chain; keep the bottle in the refrigerator and follow the beyond-use date on the label.

    Cycle length

    Typically run in courses of several weeks, with your physician deciding whether and when to repeat.

    Questions

    KPV is a three-amino-acid peptide (Lys-Pro-Val) that makes up the tail end of α-MSH, a naturally occurring hormone. The fragment has been studied, mostly in animal and cell models, for its effect on inflammatory signaling in the gut lining and skin. On EdgeRx it is compounded as a single-ingredient oral capsule.

    No. KPV is not an FDA-approved drug and has not been evaluated by the FDA for safety or effectiveness. The EdgeRx protocol is a compounded drug product prepared by a licensed U.S. 503A pharmacy for an individual patient on the basis of a physician's prescription. Compounded drug products are not reviewed or approved by the FDA.

    Much of the research on KPV has looked at the gut lining, and some of it specifically at oral delivery. The acid-resistant capsule is designed to carry the peptide past the stomach. Oral peptides are compounded only where the pharmacy holds documentation supporting oral bioavailability in humans. Your physician can walk you through what is known about oral KPV.

    No. KPV is not approved to treat any condition, and EdgeRx does not prescribe it as a treatment for a diagnosed disease. If you have a diagnosed digestive or skin condition, tell your physician during the assessment and keep working with the specialist who manages it.

    Yes. KPV on EdgeRx is prescribed by a U.S. board-certified physician after a medical assessment, for you specifically, and compounded by a licensed U.S. 503A pharmacy. Sites that sell KPV without a prescription are selling research chemicals, not a compounded medication, with no physician, no pharmacy standards, and no accountability for what is in the vial.

    We have not set a launch date. Join the waitlist on this page and we will email you when ordering opens for KPV specifically. We only email you about the protocols you asked about, and you can unsubscribe at any time.

    Join the KPV waitlist

    The KPV protocol will soon be available for purchase.

    Join the waitlist and we'll email you when ordering opens.

    Unsubscribe at any time.

    KPV is not an FDA-approved drug and has not been evaluated by the FDA for safety or effectiveness. On EdgeRx it is prepared as a single-ingredient compounded drug product by a licensed U.S. 503A compounding pharmacy for an individual patient on the basis of a physician's prescription. Compounded drug products are not reviewed or approved by the FDA. Most published research on this compound comes from animal and cell studies, and controlled human trials are limited. This page describes the compound and how the EdgeRx protocol is structured; it does not claim that KPV treats, cures, or prevents any disease. Tell your physician about every medication, supplement, and diagnosis before starting any protocol.